Dr Reddy's cancer drug hits the US market

November 25, 2014 | Tuesday | News | By BioSpectrum Bureau

Dr Reddy's cancer drug hits the US market

Docetaxel  is a  generic version of Taxotere

Docetaxel is a generic version of Taxotere

Dr Reddy's Laboratories has launched Docetaxel injection USP 20 mg/mL and 80 mg/4 mL, a generic version of Taxotere (docetaxel injection) in the US market.

According to the company, Docetaxel injection USP 20 mg/mL and 80 mg/4 mL are available as a single dose, one vial formulation that does not require a prior dilution with a diluent and is ready to add to the intravenous infusion solution.

Taxotere (docetaxel) is a cancer medication that interferes with the growth and spread of cancer cells in the body.

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy